Clinical trials with CMV-specific T cells

By Peggs KS   Mackinnon S  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 21-28

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease

By Hobeika Ac   Osada T.   Serra D.   Peplinski S.   Hanson K.   Tanaka Y.   Niedzwiecki D.   Chao N.   Rizzieri D.   Lyerly Hk   Clay T.   Morse Ma  

Cytotherapy, Vol. 10, Iss. 3, 2008-01 ,pp. : 289-302

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

By van Rhee F   Barrett J  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 3-10

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes

By Watanabe N   Kamachi Y   Koyama N   Hama A   Liang J   Nakamura Y   Yamamoto T   Isomura M   Kudo K   Kuzushima K   Kojima S  

Cytotherapy, Vol. 6, Iss. 5, 2004-10 ,pp. : 514-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC

By Ramadan G   Konings S   Kurup Vp   Keever-taylor Ca  

Cytotherapy, Vol. 6, Iss. 3, 2004-06 ,pp. : 223-234

Ashgate Publishing Ltd

Access to resources Recommend Favorite